[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352174-105":59,"doc-detail-352174-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","chek2-germline-variants-in-cancer-predisposition-whole-genome-sequencing-results","CHEK2 Germline Variants in Cancer Predisposition - Whole Genome Sequencing Results","","While pathogenic germline CHEK2 variants are known to increase cancer risk, evidence remains insufficient for the exact risk associated with specific missense variants or variants of uncertain significance, limiting clear clinical guidance for consultation, monitoring, and targeted treatment. Whole-genome sequencing data were analyzed for 3150 patients with cancer and suspected hereditary cancer syndromes and 5163 healthy controls. Results link pathogenic and likely pathogenic variants to higher breast cancer risk, quantify associations for key CHEK2 variants, and identify c.470T>C (p.Ile157Thr) as the most frequent variant in the cohort.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chek2-germline-variants-in-cancer-predisposition-whole-genome-sequencing-results/352174/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chek2-germline-variants-in-cancer-predisposition-whole-genome-sequencing-results/352174.png","ImageObject",300,407,{"name":92,"@type":93},"pixelkiddo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"Which CHEK2 variants were found to be associated with increased cancer risk?","Question",{"text":112,"@type":113},"Pathogenic/likely pathogenic variants significantly increased breast cancer risk, the c.1100del variant showed a moderate risk increase, and common P/LP variants including c.1100del, c.444+1G>A, and c.433C>T were also associated with increased risk. The study also quantified the frequency and nominal significance of c.470T>C (p.Ile157Thr).","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},352174,1790135091,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":41,"preview_page_count":19,"preview_urls":137},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","Article  \nCHEK2 Germline Variants in Cancer Predisposition: Whole Genome Sequencing Results  \nMarina V. Nemtsova 1,2,3, Maria V. Makarova 1,4, *, Anastasiia M. Danishevich 5, Maria M. Byakhova 6,  \nOlesya S. Mishina 1, Alevtina E. Kiseleva 3, Maxim S. Belenikin 1, Anastasia A. Krinitsina 1, Olesya V. Sagaydak 1, Anna B. Semenova 6, Natalia A. Bodunova 5, Igor E. Khatkov 5, Irina A. Demidova 7, Aleksey S. Tsukanov 8, Vsevolod N. Galkin 6 and Saida M. Gadzhyeva 9  \nAcademic Editor: Athanasios  \nG. Papavassiliou  \nReceived: 24 July 2026  \nRevised: 17 August 2026  \nAccepted: 20 August 2026  \nPublished: 25 August 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Evogen LLC, Fotiyevoy St., 6, b.1, 119333 Moscow, Russia; [nemtsova_m_v@mail.ru](nemtsova_m_v@mail.ru) (M.V.N.); [mishina@evogenlab.ru](mishina@evogenlab.ru) (O.S.M.); [belenikin@evogenlab.ru](belenikin@evogenlab.ru) (M.S.B.); [krinitsina@evogenlab.ru](krinitsina@evogenlab.ru) (A.A.K.); [sagaydak@evogenlab.ru](sagaydak@evogenlab.ru) (O.V.S.)  \n2 Research Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia  \n3 Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov of the Ministry of Health of Russian Federation, Trubetskaya St., 8 p. 2, 119991 Moscow, Russia; [kis-alevtina@yandex.ru](kis-alevtina@yandex.ru)  \n4 Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology of the Ministry of Health of the Russian Federation, Profsoyuznaya St., 86, 117997 Moscow, Russia  \n5 Moscow Clinical Scientific Centre Named After A.S. Loginov, Novogireevskaya St., 1 p. 1, 111123 Moscow,  \nRussia; [danishevicham@ya.ru](danishevicham@ya.ru) (A.M.D.); [n.bodunova@mknc.ru](n.bodunova@mknc.ru) (N.A.B.); [i.hatkov@mknc.ru](i.hatkov@mknc.ru) (I.E.K.)  \n6 Moscow City Clinical Hospital Named After S.S. Yudin, Kolomensky pr., 4, 115446 Moscow, Russia; [biakhovamm@mail.ru](biakhovamm@mail.ru) (M.M.B.); [asemenova81@mail.ru](asemenova81@mail.ru) (A.B.S.)  \n7 Moscow City Oncology Hospital No. 62, Bolshoy Boulevard, 67, Skolkovo Innovation Center,  \n121205 Moscow, Russia; [dema-80@yandex.ru](dema-80@yandex.ru)  \n8 Ryzhikh National Medical Research Centre for Coloproctology, Salama Adil Str., 2, 123423 Moscow, Russia; [tsukanov81@rambler.ru](tsukanov81@rambler.ru)  \n9 Moscow Healthcare Department, Oruzheyniy per., 43, 127006 Moscow, Russia  \n* [Correspondence: maria.makarova.work@gmail.com](Correspondence: maria.makarova.work@gmail.com)  \nAbstract  \nWhile pathogenic germline CHEK2 variants are known to increase cancer risk, there is currently insufficient evidence regarding the precise risk of developing malignant neoplasms associated with specific missense variants or variants of uncertain significance. As a result, no clear clinical guidelines exist regarding consultation, monitoring and specific treatment options for those patients. For the first time in Russia, clinical data and whole-genome sequencing (WGS) results were analyzed for 3150 patients with cancer and suspected hereditary cancer syndromes (HCS) and 5163 healthy individuals. This dataset formed the basis for assessing the role of germline CHEK2 variants in the development of different cancer types. The chromosomal coordinates and coding sequence coordinates are given in accordance with the GRCh38 (hg38) genome assembly and the NM_007194.4 transcript. Pathogenic (P) and likely pathogenic (LP) variants of CHEK2 significantly increased the risk of breast cancer (OR = 2.015 [95% CI: 1.27–3.21]; p = 0.0031), but the association with colorectal cancer was not statistically significant (OR = 1.354 [95% CI: 0.42–4.42]; p = 0.616). A moderate increase in cancer risk was identified for the c.1100del variant (OR = 2.263 [95% CI: 1.19–4.32]; p = 0.0132) and for the common P/LP variants c.1100del, c.444+1G>A and c.433C>","cbCaieFYvY1vpXBO","https://ap.wps.com/l/cbCaieFYvY1vpXBO","pdf",370416,12,"English","# Abstract\n# Introduction\n# Methods and Cohort (whole-genome sequencing, case/control design)\n# Results (risk estimates by variant type and cancer type)\n# Discussion and Clinical Implications (interpretation and need for further studies)","[{\"question\":\"Which CHEK2 variants were found to be associated with increased cancer risk?\",\"answer\":\"Pathogenic/likely pathogenic variants significantly increased breast cancer risk, the c.1100del variant showed a moderate risk increase, and common P/LP variants including c.1100del, c.444+1G\\u003eA, and c.433C\\u003eT were also associated with increased risk. The study also quantified the frequency and nominal significance of c.470T\\u003eC (p.Ile157Thr).\"}]","CHEK2 Germline Variants in Cancer Predisposition - Whole Genome Sequencing Results | PDF",1790098108,[138,142,146,150],{"page_no":8,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7eda7031bd81db2cdcdb1e8828c90bcc.webp",983,1390,{"page_no":14,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61cb331a357bd811337296dafd3af4b5.webp",982,1388,{"page_no":81,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb4490e984f63161b2ff70f467e8b389.webp",981,1387,{"page_no":19,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88fbc7fd4ac8715015b679798d9e4e34.webp",980,1385]